Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 24602760

Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Apr
First author
Ardeshna KM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Apr;15(4):368-9. doi: 10.1016/S1470-2045(14)70066-X.
    note
    Source null
    related pmid
    24602759
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2014 Jun;15(7):e251-2. doi: 10.1016/S1470-2045(14)70215-3.
    note
    Source null
    related pmid
    24872108
    relationship
    Comment in

Authors and identifiers

  1. name
    Ardeshna KM
    type
    Author
  2. name
    Qian W
    type
    Author
  3. name
    Smith P
    type
    Author
  4. name
    Braganca N
    type
    Author
  5. name
    Lowry L
    type
    Author
  6. name
    Patrick P
    type
    Author
  7. name
    Warden J
    type
    Author
  8. name
    Stevens L
    type
    Author
  9. name
    Pocock CF
    type
    Author
  10. name
    Miall F
    type
    Author
  11. name
    Cunningham D
    type
    Author
  12. name
    Davies J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ardeshna KM
    type
    Author
  2. name
    Qian W
    type
    Author
  3. name
    Smith P
    type
    Author
  4. name
    Braganca N
    type
    Author
  5. name
    Lowry L
    type
    Author
  6. name
    Patrick P
    type
    Author
  7. name
    Warden J
    type
    Author
  8. name
    Stevens L
    type
    Author
  9. name
    Pocock CF
    type
    Author
  10. name
    Miall F
    type
    Author
  11. name
    Cunningham D
    type
    Author
  12. name
    Davies J
    type
    Author
bibliography ids
  1. nci-bib-be4633198aefa57c13ffb315
book metadata
content sha256
fcc05132bbf6754ba674faeddec16f307ad082c11b3950b1fb53eae0e1d96ac5
document type
citation
dois
  1. 10.1016/S1470-2045(14)70027-0
electronic publication date
display
2014 Mar 4
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24602760
immutable id
pubmed:24602760@fcc05132bbf6754ba674faeddec16f307ad082c11b3950b1fb53eae0e1d96ac5
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
4
name
The Lancet. Oncology
nlm unique id
100957246
pages
424-35
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Apr;15(4):368-9. doi: 10.1016/S1470-2045(14)70066-X.
    note
    Source null
    related pmid
    24602759
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2014 Jun;15(7):e251-2. doi: 10.1016/S1470-2045(14)70215-3.
    note
    Source null
    related pmid
    24872108
    relationship
    Comment in
outcomes validated
false
pmid
24602760
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
1e77d52849eb98e7c1b51225e256a793baa583c9a0684ea595ec321b441ba38e
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 Apr
precision
month
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24602760/
title
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial.

Preserved source evidence · Independent clinical review pending · Not medical advice